DEIDRE SHAY: Open Payments
NPI 1225883119 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 38 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $356 · 2025 $2,239
Travel & lodging: $1,157Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $1,229 |
| ABIOMED | 7 | $340 |
| Merck Sharp & Dohme LLC | 9 | $218 |
| Novo Nordisk Inc | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Amgen Inc. | 3 | $51 |
| Boston Scientific Corporation | 1 | $28 |
| Edwards Lifesciences Corporation | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
Products named: CARDIOMEMS, VERQUVO, Wegovy, LEQVIO, Kerendia, REPATHA, CAPVAXIVE, CDS broad portfolio offering.
Industry payments across CA — which companies pay providers there.
